logo
Share SHARE
FONT-SIZE Plus   Neg

Covidien Agrees To Buy Israeli Medical Device Maker

U.S. medical device maker Covidien (COV) has reached a definitive agreement to acquire Super-Dimension, the Israeli manufacturer of pulmonary devices. The purchase price for the deal is nearly $300 million, with some future payments possible, contingent on the performance of the company.

Super-Dimension's i·main product is its Logic System, which uses Electromagnetic Navigation Bronchoscopy. This high-tech method of navigation allows health professionals access to lesions deep in the lungs as well as in mediastinal lymph nodes.

The acquisition may close in the second calendar quarter of 2012.

Assuming a second calendar quarter 2012 closing, Covidien does not anticipate this transaction to have a material impact on its fiscal 2012 sales. Upon the close of the transation, Covidien would report the superDimension business in the Endomechanical product line within the Medical Devices segment.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
German telecom giant Deutsche Telekom AG reported Wednesday that its first-quarter net profit quadrupled on hefty stake sale gain. Revenues also increased on US strength, while domestic revenues were weak. Royal Dutch Shell reported Wednesday a pre-tax loss in its first quarter, while CCS earnings plunged from last year mainly on weak revenues. Oil and gas production increased but that was offset by lower prices. Further, the company announced dividend, and warned on second-quarter earnings. Shares of French lender Societe Generale SA were gaining around 4 percent in the early morning trading in Paris after the company reported Wednesday higher profit in its first quarter, even as net banking income was weak. Looking ahead, Chief Executive Officer Frédéric Oudéa said, "With a sound balance sheet and robust solvency ratios, the Group is confident about its outlook for 2016,..
comments powered by Disqus
Follow RTT